R ROSEMONT

Serial Number 97258471
Registration 7362691
700

Registration Progress

Application Filed
Feb 8, 2022
Under Examination
Approved for Publication
Feb 6, 2024
Published for Opposition
Feb 6, 2024
Registered
Apr 23, 2024

Trademark Image

R ROSEMONT

Basic Information

Serial Number
97258471
Registration Number
7362691
Filing Date
February 8, 2022
Registration Date
April 23, 2024
Published for Opposition
February 6, 2024
Drawing Code
5

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 23, 2024
Registration
Registered
Classes
005 042 044

Rights Holder

Rosemont Pharmaceuticals Ltd

99
Address
WRAFTON, BRAUNTON
DEVON EX332DL
GB

Ownership History

Rosemont Pharmaceuticals Ltd

Original Applicant
99
Leeds GB

Rosemont Pharmaceuticals Ltd

Owner at Publication
99
Leeds GB

Rosemont Pharmaceuticals Ltd

Original Registrant
99
DEVON GB

Legal Representation

Attorney
Bradley M. Stohry

USPTO Deadlines

Next Deadline
1724 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-04-23)
Due Date
April 23, 2030
Grace Period Ends
October 23, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

23 events
Date Code Type Description Documents
Jul 17, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jul 17, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 17, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jul 17, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jul 17, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 23, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Apr 23, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Feb 6, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Feb 6, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 17, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 30, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 22, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 22, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 22, 2023 ALIE A ASSIGNED TO LIE Loading...
Jun 20, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Apr 6, 2023 XELG O APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED Loading...
Apr 6, 2023 XELR I APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED Loading...
Jan 9, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 9, 2023 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 9, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 19, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 14, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 11, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for patients sufferings from dysphagia or otherwise requiring medication in liquid form; sanitary preparations for medical use; dietetic preparations adapted for medical purposes substances; drugs, medicines and medical preparations, namely, oral liquid medicines, oral suspensions, dispersible or soluble tablets, and powders to be consumed in liquid form that facilitate the delivery of pharmaceutical preparations
Class 042
Scientific research; research and testing relating to drugs, pharmaceuticals, medicines and medical preparations and consultation regarding drug development
Class 044
Medical and pharmaceutical consultation

Additional Information

Design Mark
The mark consists of the word "ROSEMONT" underneath a stylized letter "R".
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005 042 044